Denali Therapeutics, Inc. (DNLI)
18.92
+0.81
(+4.47%)
USD |
NASDAQ |
May 20, 11:57
Denali Therapeutics Total Assets (Quarterly) : 1.266B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.48B |
| Neurocrine Biosciences, Inc. | 4.906B |
| Arcturus Therapeutics Holdings, Inc. | 245.41M |
| Agenus, Inc. | 186.46M |
| Curis, Inc. | 29.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 339.92M |
| Shareholders Equity (Quarterly) | 926.10M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 9.285 |
| Net Debt Paydown Yield | 0.09% |